MRNA - Moderna

-

$undefined

N/A

(N/A)

Moderna NASDAQ:MRNA Moderna, Inc is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts. It focuses on drug discovery, drug development, and vaccine technologies based on messenger RNA.

Location: 200 Technology Sq, Massachusetts, 02139-3578, US | Website: www.modernatx.com | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

9.303B

Cash

6.867B

Avg Qtr Burn

-801.8M

Short % of Float

10.89%

Insider Ownership

9.52%

Institutional Own.

71.70%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
mRESVIA (mRNA-1345) Details
Respiratory syncytial virus

Approved

Update

Approved

Quarterly sales

Approved

Quarterly sales

BLA

Submission

mRNA-1403 Details
Norovirus, Gastroenteritis

Phase 3

Data readout

Phase 3

Data readout

mRNA-4157/V940 +KEYTRUDA Details
Cancer, Non-small cell lung carcinoma

Phase 3

Data readout

mRNA-1647 Details
Cytomegalovirus

Phase 3

Data readout

mRNA-1083 Details
COVID-19, Influenza

Phase 3

Update

Phase 3

Update

mRNA-3705 Details
Rare diseases, Methylmalonic acidemia

Phase 1/2

Data readout

mRNA-1468 Details
Varicella-zoster virus

Phase 1/2

Data readout

mRNA-3927 Details
Propionic acidemia

Phase 1/2

Update

mRNA-1574 Details
Human immunodeficiency virus

Phase 1

Data readout